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Abstract
Background: Single Nucleotide Polymorphisms (SNPs) are an important source of human genome variability. Non-
synonymous SNPs occurring in coding regions result in single amino acid polymorphisms (SAPs) that may affect
protein function and lead to pathology. Several methods attempt to estimate the impact of SAPs using different
sources of information. Although sequence-based predictors have shown good performance, the quality of these
predictions can be further improved by introducing new features derived from three-dimensional protein
structures.
Results: In this paper, we present a structure-based machine learning approach for predicting disease-related SAPs.
We have trained a Support Vector Machine (SVM) on a set of 3,342 disease-related mutations and 1,644 neutral
polymorphisms from 784 protein chains. We use SVM input features derived from the protein’s sequence, structure,
and function. After dataset balancing, the structure-based method (SVM-3D) reaches an overall accuracy of 85%, a
correlation coefficient of 0.70, and an area under the receiving operating characteristic curve (AUC) of 0.92. When
compared with a similar sequence-based predictor, SVM-3D results in an increase of the overall accuracy and AUC
by 3%, and correlation coefficient by 0.06. The robustness of this improvement has been tested on different
datasets and in all the cases SVM-3D performs better than previously developed methods even when compared
with PolyPhen2, which explicitly considers in input protein structure information.
Conclusion: This work demonstrates that structural information can increase the accuracy of disease-related SAPs
identification. Our results also quantify the magnitude of improvement on a large dataset. This improvement is in
agreement with previously observed results, where structure information enhanced the prediction of protein
stability changes upon mutation. Although the structural information contained in the Protein Data Bank is limiting
the application and the performance of our structure-based method, we expect that SVM-3D will result in higher
accuracy when more structural date become available.
Background
In recent years, though the cost of genomic experiments
has decreased rapidly, the interpretation of their results
is still an open problem. The complete sequencing of
the human genome in 2003 [1] led to the identification
of millions of Single Nucleotide Polymorphisms (SNPs)
by the HapMap Consortium project [2] and the Human
Variation project [3]. This created a significant need for
bioinformatics tools to analyze the large amount of data
to detect functional SNPs and describe their molecular
effects. Currently the number of validated SNPs in the
dbSNP database is greater than 20 million [4]. In gen-
eral, mutations occurring in coding regions may have a
greater impact on the gene’s functionality than those
occurring in non-coding regions [5]. Only a small frac-
tion of SNPs (~60,000) corresponds to the subset of
annotated missense coding SNPs [6]. For this subset of
Single Amino acid Polymorphisms (SAPs), curators of
the Swiss Institute of Bioinformatics classify them into
disease-related SAPs and neutral SAPs, according to the
corpus of peer-reviewed literature. In the last few years,
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several methods have been developed to predict the
impact of a given SAP [7-26]. These algorithms are able
to predict the effect of the mutation on protein stability
[13,14,19,23-26], protein functional activity [9,21], and
insurgence of human pathologies [7,8,10-12,15-
18,20-22]. The majority of methods rely on information
derived from protein sequence [7,11,12,17], while others
use protein structure data [8,15,20,22,27-29] and knowl-
edge-based information [10,16,18]. In particular, SIFT
[30] and PolyPhen2 [18] rely on different representa-
tions of evolutionary information. SIFT scores the nor-
malized probabilities for all possible substitutions at a
mutated site using a multiple sequence alignment of
homologous proteins. PolyPhen2 predicts the impact of
variants by calculating a Position Specific Independent
Counts (PSIC) matrix from a multiple sequence align-
ment. Protein family specific HMM models have also
been implemented in PANTHER [7] to detect deleter-
ious mutations. Machine learning-based approaches
such as PhD-SNP [12] and SNAP [9] have shown better
results with respect to traditional approaches. Recently
described methods rely on knowledge-based information
to reach overall accuracy greater than 80%. For instance,
SNPs&GO [10] includes a new log-odd score calculated
from GO terms, and MutPred [16] uses different
machine learning approaches to evaluate the probabil-
ities of gain or loss of predicted structural and func-
tional properties. The structural context of the
mutations has been studied to determine the mechanism
of action of each mutation at the protein level [8]. In
addition, protein three-dimensional structural features
have been used to improve the prediction of the impact
of SAPs on protein function [21] and human health
[22,31]. Although the predictive power of protein struc-
tural information has been established, a quantitative
comparison between structure-based and sequence-
based methods is still needed. In this paper, we focus
our attention on the prediction of disease-related SAPs
using a novel machine learning-based method that takes
as input, protein sequence, protein structure, and pro-
tein function information (SVM-3D). For the fist time,
we predict deleterious single point mutations consider-
ing in a unique framework protein structure informa-
tion, used for the prediction of stability changes in I-
Mutant [13,23], and protein sequence, evolutionary and
functional information, used in the recently developed
SNPs&GO algorithm [10]. To quantify the improvement
of the performance resulting from the use of protein
structure information, we compared the accuracy of
SVM-3D against a similar sequence and function-based
method (SVM-SEQ) [10], SIFT [30] and PolyPhen2 [18].
In particular, the comparison with PolyPhen2 [18] is
more appropriate because it considers in input struc-
tural features such as secondary structures, solvent
accessibility and normalized B factor of the mutated
residue. The results show that protein three-dimensional
structure information increases the accuracy in detec-
tion of deleterious SAPs and can provide insight about
the disease mechanism.
Results
Performance of the method
In the last decades, machine learning approaches have
been successfully used to address several biological pro-
blems and develop new prediction tools. We modified a
previously developed predictor [10] by introducing
three-dimensional structure information. In particular,
we used new features to describe the structural environ-
ment of the mutation, examining the protein elements
within a radius of 6 Å around the C-a atom (see Figure
1). To quantify the improvement in accuracy resulting
from the use of 3D structure information, we compared
the performance of our structure-based method (SVM-
3D) with a sequence-based one (SVM-SEQ). In Table 1
are reported different accuracy measurements for both
predictors tested on B3D dataset (see Methods). The
structure-based method results in 3% improvement in
overall accuracy and 0.06 higher correlation. Comparing
the ROC curves (Figure 2 A), SVM-3D gives 0.03 better
Area Under the Curve (AUC) with respect to SVM-
SEQ. If 10% of wrong predictions are accepted, SVM-
3D has 7% more true positives. The output returned by
the SVM has been used to calculate the Reliability Index
(RI) in order to filter predictions. If predictions with
RI>5 are selected, the SVM-3D method achieves 91%
overall accuracy and 0.82 correlation coefficient on 78%
of the whole dataset (see Figure 1 B). Analyzing the pre-
dictions of SVM-SEQ and SVM-3D, we found that the
outputs agree in the 91% of the cases. On this subset,
the overall accuracy is 87% and the correlation coeffi-
cient of the method is 0.74. For the remaining 9% of the
predictions, SVM-SEQ results in very poor overall accu-
racy and correlation, 34% and -0.32, respectively. SVM-
3D performs slightly better than random, giving 66%
overall accuracy and 0.32 correlation coefficient (see
Table 2).
Comparison with other methods
The accuracy of our SVM-based methods has been
compared with SIFT and PolyPhen2. To score the per-
formance of the methods on a set composed with highly
reliable neutral polymorphism, we calculated their accu-
racy on N3D dataset. The results in Table 3 show that
SVM-3D has 2% higher accuracy and 3% higher correla-
tion coefficient with respect to the PolyPhen2 and
SVM-SEQ. In addition SVM-3D and SIFT result in 79%
sensitivity in the prediction of neutral polymorphism
that is 3% higher than the same value reached by SVM-
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SEQ and PolyPhen2. Although the level of improvement
is slightly lower with respect to previously reported data,
we should note that it has been obtained only on ~12%
of the whole A3D dataset.
To evaluate the minimum level of improvement
resulting from the use of protein structure information,
we performed a more stringent test using a set of muta-
tions (KIN) occurring in proteins annotated with the
Gene Ontology term “Kinase activity” (GO:0016301).
Our SVM-based methods have been trained on a dataset
(noKIN) without any protein with “Kinase Activity” and
without any significant sequence similarity to proteins
in KIN dataset. To keep the number of disease-related
and neutral polymorphism balanced, in the training step
the neutral variants have been doubled considering their
reverse mutations. We have compared the performances
of our sequence (SVM-SEQ) and structure-based (SVM-
3D) methods against SIFT and PolyPhen2. The scores
obtained on KIN dataset confirm that SVM-3D results
in 3% higher accuracy and more than 3% correlation
with respect to SIFT and PolyPhen2 (see Table 4).
These values represent a significant lower bound level of
improvement (probability c2 ≤ 0.01) since in the noKIN
training set there is not any protein with significant
sequence similarity (e-value >10-3) to proteins in KIN
dataset. In addition, all functional information associated
to GO:0016301 and its sub annotations are not consid-
ered for the calculation of the LGO score in the KIN
dataset. In this test, performed on a lower number of
mutations, although the improvement of the perfor-
mances between SVM-SEQ and SVM-3D is not
Figure 1 Flow chart of our SVM-based methods. The structure-based method (SVM-3D) takes in input mutation (yellow) structure environment
(in blue), sequence profile (green), PANTHER output (pink) and function (gray) information. In the sequence-based method (SVM-SEQ) the 21
elements vector encoding for the structural environment is replaced by the 20 elements vector encoding for the sequence environment. The
structure environment is the residue composition in a 6 Å radius shell around the C-a of the mutated residue. The sequence environment is the
amino acid composition window of 19 residues centred on the mutated residue.
Table 1 Performances of the sequence (SVM-SEQ) and
structure (SVM-3D) based methods
Q2 P[D] S[D] P[N] S[D] C AUC
SVM-SEQ 0.82 0.81 0.83 0.82 0.81 0.64 0.89
SVM-3D 0.85 0.84 0.87 0.86 0.83 0.70 0.92
The accuracy measures are defined in Methods section. D and N are disease-
related and neutral variants respectively. Methods are tested on the B3D
dataset.
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significant (probability c2 = 0.25), SVM-3D is still result-
ing in 2% higher accuracy and 0.03 higher correlation
coefficient with respect to SVM-SEQ.
Structure environment analysis
Protein three-dimensional structural information is an
important feature for predicting the effects of SAPs. Ana-
lysis of the protein structure provides information about
the environment of the mutation. In fact, the effect of a
mutation depends critically upon the location of the resi-
due, specifically if it is buried in the hydrophobic core or
exposed on the surface of the protein. In Figure 3 panel
A, we plot the distributions of the relative solvent acces-
sible area (RSA) for disease-related and neutral variants.
The two distributions have mean RSA values of 20.6 and
35.7 for disease-related and neutral variants, respectively
(see Figure 3 panel A). They are significantly different
and the Kolmogorov-Smirnov test results in a p-value of
2.8·10-71. We calculated the overall accuracy and correla-
tion coefficient of our method dividing the dataset in 10
bins according to RSA value of the mutated residue. The
SVM-3D method shows better performance in the pre-
diction of buried (RSA<20) and highly exposed (RSA>80)
mutated residues (see Figure 3 panel B).
Scoring the residue interactions
Protein structure gives insight to the interactions
between residues far in primary sequence but close in
3D space. We defined two types of interactions: the
“lost” interactions are those missing as a direct result of
the mutation event and the “gained” interactions are
those expected to be formed by the new (mutant) resi-
due. We compared the frequency of lost and gained
interactions in the context of disease or neutral muta-
tions. In Figure 4 panels A and B, we show the log-odd
scores for lost and gained interactions, respectively.
Figure 2 Performance of the structural-based method. In panel (A), ROC curves of the sequence (SVM-SEQ) and structure-based methods (SVM-
3D). The plot shows the improvement of 3% in AUC and 7% in TPR when sequence and structure base methods are compared. In panel B,
accuracy and correlation coefficient of SVM-3D as function of the Reliability Index (RI). If predictions with RI>5 are selected the SVM-3D method
results in 91% overall accuracy 0.82 correlation coefficient over 78% of the dataset. Accuracy measures (Q2, C, TPR and FPR) are defined in
Methods section. DB is the fraction of the whole dataset of mutations.
Table 2 Performances on agree and not agree subset of
predictions
Q2 P[D] S[D] P[N] S[D] C AUC PM
SEQ∩3D 0.87 0.85 0.89 0.89 0.84 0.74 0.93 91
SEQ-3D 0.66 0.70 0.70 0.62 0.62 0.32 0.71 9
3D-SEQ 0.34 0.38 0.30 0.30 0.38 -0.32 0.35 9
SEQ∩3D indicates the subset of agree predictions between SVM-3D and SVM-
SEQ. SEQ-3D and 3D-SEQ are respectively the predictions of SVM-SEQ and
SVM-3D on the not agree prediction subset. The accuracy measures are
defined in Methods section. PM is the fraction of the dataset. D and N are
disease-related and neutral variants respectively.
Table 3 Comparison with other methods on the N3D
dataset
Q2 P[D] S[D] P[N] S[D] C AUC PM
SIFT 0.77 0.77 0.74 0.76 0.79 0.53 0.83 96
PolyPhen2 0.80 0.78 0.83 0.82 0.76 0.60 0.86 99
SVM-SEQ 0.80 0.78 0.84 0.82 0.76 0.59 0.86 100
SVM-3D 0.82 0.80 0.85 0.84 0.79 0.63 0.89 100
The accuracy measures are defined in Methods section. D and N are disease-
related and neutral variants respectively. PM is the predicted fraction of the
dataset. Methods are tested on N3D dataset.
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According to these results, the most deleterious lost
contacts are between cysteines (Cys-Cys) and the most
damaging gained interactions are between tryptophans
(Trp-Trp). A missing Cys-Cys interaction can lead to
the loss of a disulphide bond that strongly contribute to
the protein’s stability by modulating the hydrophobicity
of both native and denatured states [32]. The mutation
of a residue to a tryptophan when close to other aro-
matic residues can stabilize the structure but may
increase the protein aggregation rate [33].
We discuss two examples where sequence-based
method wrongly classifies two disease-related variants
while structure-based algorithm is able to predict them
correctly. An example of lost Cys-Cys interaction is the
mutation of Cys163 in Glycosylasparaginase (Swiss-Prot:
ASPG_HUMAN). This mutation is responsible for the
insurgence of Aspartylglucosaminuria (MIM:208400).
Visual inspection of the protein structure (Figure 5)
shows that mutation of Cys163 to Serine results in the
loss of the disulfide bridge between Cys163 and Cys179
(respectively Cys140 and Cys156 in the PDB structure
1APY chain A). An interesting example of a possibly
damaging gained interaction can be observed in the
Thyroid hormone receptor (Swiss-Prot:THB_HUMAN),
where mutation of Arg243 to tryptophan is cause of
Thyroid hormone resistance (MIM:188570,274300).
Analyzing the protein structure (1NAX chain A), we
expect that the new tryptophan will be in proximity to
another tryptophan in position 239 and a phenylalanine
in position 245. Thus, this mutation could result in
stereo-chemical problems in the pocket around the posi-
tion 243 (see Figure 6). In addition after mutation, the 3
aromatic residues (Trp239, Trp243, Phe245) in the
exposed region could increase aggregation rate of the
protein. The case of Cys163Ser variant in Glycosylaspar-
aginase is a good example where structure-based
method SVM-3D results in correct prediction because it
able to capture the disulfide bond between Cys163 and
Cys179 that is not described by the local sequence
environment represented in SVM-SEQ.
Discussion
The results of this work show that protein structure
information increases the accuracy of the prediction of
deleterious mutations. The increments of 3% in overall
accuracy and AUC, and 6% in correlation coefficient,
with respect to the sequence-based method, are compar-
able with the improvement of the performance obtained
using protein function information [10]. Although this
gain is significant (probability c2 = 4·10-7), it is not as
high as expected. In the next future, higher number of
mutations from proteins with known structure will
increase the performances of structure-based methods
with respect to sequence-based ones. The Protein Data
Bank (PDB) only contains a subset of structures
Table 4 Comparison with other methods on the KIN
dataset
Q2 P[D] S[D] P[N] S[D] C AUC PM
SIFT 0.80 0.90 0.84 0.58 0.69 0.50 0.81 99
PolyPhen2 0.80 0.88 0.86 0.60 0.63 0.48 0.81 98
SVM-SEQ 0.81 0.87 0.88 0.63 0.62 0.50 0.82 100
SVM-3D 0.83 0.87 0.91 0.69 0.59 0.53 0.83 100
The accuracy measures are defined in Methods section. D and N are disease-
related and neutral variants respectively. PM is the predicted fraction of the
dataset. Methods are tested on KIN dataset.
Figure 3 Analysis of the protein three-dimensional structure environment. In panel (A) the distribution of the relative solvent accessible area
(RSA) for disease-related and neutral variants. The significant difference of their distributions makes the RSA a good feature to discriminate
between disease-related and neutral variants. In panel (B) we report the accuracy of SVM-3D predictions as a function of the RSA. The plot
shows that the accuracy of SVM-3D is lower in exposed regions with respect to buried ones. Accuracy measures (Q2, C and AUC) are defined in
Methods section. DB is the fraction of the whole dataset for disease-related (D) and neutral (N) mutations.
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describing mutant proteins and the quaternary interac-
tions. Due to these limitations, our method only takes in
to account structural information about the wild-type
protein and intra-chain tertiary interactions. This model
is a good approximation to describe the structural envir-
onment of the buried residues but it is not appropriate
for exposed residues. This limitation justifies the lower
level of accuracy observed for exposed residues (see
Figure 3B). In particular, for mutated residues with
more than 40% exposed surface the correlation coeffi-
cient of the predictions is lower than the mean correla-
tion coefficient resulting from the sequence-based
predictor. The limitations of our algorithm to describe
the structural changes and the environment of exposed
residues make the gain of 3% in accuracy and AUC a
lower bound estimation of the improvement. Similar
Figure 4 Log-odd score for lost residues interactions (A) and for gained interactions (B). The red and blue zones correspond to damaging and
neutral interactions respectively. The mutations resulting in the lost of a Cys-Cys and the gain of Trp-Trp interactions are mainly associated to
insurgence of disease.
Figure 5 Structure of the Glycosylasparaginase (PDB code 1APY
chain A) and details of the region around Cys163 (in blue). Residues
in cyan and Cys179 (yellow) are below 6 Å. Residues 163 and 179
are numbered respectively 140 and 159 in the PDB file.
Figure 6 Structure of the Thyroid hormone receptor (PDB code
1NAX chain A) and details of the region around the Arg243 (blue).
Residues in cyan and Trp239 (yellow) are below 6 Å.
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level of improvement has been obtained in the stringent
test of KIN dataset where, without “Kinese Activity”
functional information and homolog proteins in the
training set, our structure-based method resulted in
~3% higher accuracy and AUC with respect to SIFT and
PolyPhen2. These results are particularly encouraging
because the SVM-3D method reaches higher level of
accuracy with respect to PolyPhen2, which includes pro-
tein structure information in the input features. Accord-
ing to these observations, further improvements of our
structure-based method will require the knowledge of
the three-dimensional structure of the mutated proteins
and the protein-protein interactions.
Conclusion
We developed a new machine learning approach that
integrates protein structure information to predict the
effects of SAPs. To quantify the increase in accuracy
achieved by protein structure information, we compared
our method to a previously developed sequence-based
predictor. Using a balanced set of 6,630 mutations, the
structure-based method results in about 3% higher accu-
racy and AUC and 0.06 higher correlation with respect
to the sequence-based approach. In addition, our SVM-
3D approach results in 3% better accuracy and AUC
with respect to SIFT and PolyPhen2. Although the
increase in performance is not extremely high, the intro-
duction of structure information provides insight about
disease mechanism. The prediction improvement is also
in agreement with previous results, where structure
information enhanced the prediction of protein stability
change upon amino acid mutation [13].
Methods
Datasets
The performance of machine learning methods strongly
depends on the training set. Thus, the selection of a
representative and unbiased set of SAPs is an important
issue in the development of predictive algorithms. A
previous analysis of different SAPs databases has shown
annotated variants from the Swiss-Var database to be
the best [34]. According to this observation, we selected
our set of SAPs from Swiss-Var release 57.9 (Oct 2009)
and then mapped the variants to protein structures
from the Protein Data Bank (PDB) [35]. We used a pre-
compiled list of correspondences between Swiss-Prot
and PDB codes available at the ExPASY web site. Using
this mapping, we aligned each pair of sequences using
the BLAST algorithm [36] and then filtered out align-
ments with: i) gaps, ii) sequence identity lower than
100%, and iii) shorter than 40 residues. The remaining
alignments were used to calculate the correspondence
between the Swiss-Prot and PDB residue numerations.
In the case where a mutation mapped to more than one
protein structure, the structure with best resolution was
used. After this filtering procedure, we obtained a set of
4,986 mutations from 784 protein chains (A3D). Specifi-
cally, this corresponds to 3,342 disease-related SAPs and
1,644 neutral polymorphisms. To keep the dataset
balanced, we doubled the number of neutral variants by
considering their reverse mutation as neutral. The final
dataset (B3D) was therefore composed by 6,630 muta-
tions, about equally distributed between disease-related
and neutral SAPs. The performance of our algorithm
has been evaluated considering a well characterized sub-
set of neutral polymorphism mapped on dbSNP data-
base and with minor allele frequency higher than 0 in
the three main populations (CEU, YRI and HCB/JPT).
This subset consists of 311 neutral mutations annotated
as with higher reliability. To perform this second test,
we build the N3D dataset that is composed by pre-
viously selected 311 neutral polymorphisms and the
same number of randomly selected deleterious muta-
tions from A3D dataset.
To estimate the lower level of improvement in the pre-
diction performance, resulting from using structural
information, we performed another test selecting the
subset of mutations occurring in proteins annotated with
the “Kinase activity” Gene Ontology term (GO:0016301).
This dataset (KIN) is composed by 492 mutations in 75
protein chains 369 of which are annotated as disease-
related and the remaining 123 as neutral polymorphisms.
The performances of the method are evaluated training
our machine learning approach on the remaining set of
mutations corresponding to proteins not annotated with
GO:0016301 term. To make the test more stringent, we
also removed from the training set those mutations
occurring in proteins which have one BLAST hit to KIN
proteins with e-value lower than 10-3. After this proce-
dure, the final training set of non-kinase mutations
(noKIN) is composed by 4,379 mutations from 671 pro-
tein chains of which 2,919 disease-related and 1,460 neu-
tral polymorphisms. The composition of the datasets
used in this work is summarized in Table 5 and all data
are available in the Additional file 1.
Implemented SVM-based predictors
The addressed task is to predict whether a given single
amino acid polymorphism is neutral or disease-related.
Table 5 Composition of the datasets
Total Disease Neutral PDB Chains
A3D 4,986 3,342 1,644 784
B3D 6,630 3,342 3,288 784
N3D 622 311 311 328
KIN 492 369 123 75
noKIN 4,379 2,919 1,460 671
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The task is defined as a binary classification problem for
the protein undergoing mutation. The Support Vector
Machine (SVM) input features for the structure-based
predictor include the amino acid mutation, the muta-
tion’s structural environment, the sequence-profile
derived features, and the functional-based log-odds
score calculated from the GO classification terms (see
Figure 1). The final input vector consisted of 52
elements:
• 20 components encoding for the mutations (Mut)
• 21 features representing local protein structure
(Structure Environment)
• 5 features derived from sequence profile (Prof)
• 4 features from the output of PANTHER method
(PANTHER)
• 2 elements encoding the number of GO terms asso-
ciated to the protein and the GO log-odd score (LGO).
A similar sequence-based SVM predictor has been
used to measure the increase in accuracy stemming
from the use of protein three-dimensional structure
information [10]. The structure-based SVM differs only
in the 21 elements encoding for the local protein struc-
ture environment (Structure Environment). These
replace the 20 elements encoding for the sequence
environment used by the sequence-based SVM predictor
(see Figure 1).
Encoding residue mutation
The input vector relative to mutation consists of 20
values corresponding to the 20 residue types. It expli-
citly defines the mutation by setting the element corre-
sponding to the wild-type residue to -1 and the newly
introduced residue to 1 (all the remaining elements are
kept equal to 0).
Encoding mutation structure environment
The protein structural environment is encoded with a
21 elements vector. The first 20 features encode the
count for each residue type proximal to the mutated
residue. Proximal residues must have at least one heavy
atom within a given distance of the C-a atom of the
mutated residue. After an optimization procedure, a dis-
tance cutoff of 6 Å was selected. The 21st element is the
relative solvent accessible area (RSA) calculated using
the DSSP program [37].
Encoding mutation sequence environment
The 20 elements input values for the mutation sequence
environment match the 20 residue types. They track the
occurrence of each residue type in proximity in primary
sequence to the mutated residue. Included positions are
those found inside a window centered on the mutated
residue and that symmetrically spans the sequence to
the left (N-terminus) and to the right (C-terminus) with
a total length of 19 [12].
Encoding sequence profile information
We derived for each mutation the sequence profile,
comprising: the frequency of the wild-type (FW), the fre-
quency of the mutated residue (FN), the number of
totally (NT) and locally aligned sequences (NS), and a
conservation index (CI) [38] for the position at hand.




where fa(i) is the relative frequency of residue a at
mutated position i and fa is the overall frequency of the
same residue in the alignment. The sequence profile is
computed from the output of the BLAST program [36]
run on the uniref90 database (Oct 2009) (E-value
threshold=10-9, number of runs=1).
PANTHER features
The 4 elements vector from PANTHER [39] output is
composed by the probability of deleterious mutation
(PD), the frequencies of the wild-type (PW) and new (PN)
residues in the PANTHER family alignment and the
number of independent counts (NIC). In case that
PANTHER does not return any output the PD is set to
0.5 and the remaining value have been set to 0.
Functional based score
The Gene Ontology log-odds score (LGO) provides
information about the correlation among a given muta-
tion type (disease-related and neutral) and the protein
function. LGO score was previously introduced to anno-
tate cancer or non-cancer gene sets [40]. Recently, this
log-odd score has been extended and used to distinguish
between disease-related and neutral genes [10]. For each
GO term, the frequency of mutants in the disease-related
subset was compared to that in the neural subset and the
log-odds score was calculated. The annotation data are
relative to the GO Database (version Mar 2010) and are
retrieved at the web resource hosted at European Bion-
formatics Institute (EBI). To calculate the LGO, first we
derived the GO terms from all three branches (molecular
function, biological process and cellular components) for
all our proteins in the dataset. For each annotated term
the appropriate ontology tree has been used to retrieve
all the parent terms with the GO-TermFinder tool
(http://search.cpan.org/dist/GO-TermFinder/) [41]. Each
GO term has been counted only once. The log-odds
score associated to each protein is calculated as:
LGO=ΣGO log2[fGO(D)/fGO(N)] (2)
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where fGO is the frequency of occurrence of a given
GO term for the disease-related (D) and neutral muta-
tions (N) adding one pseudo-count to each class. To
prevent overfitting, the LGO scores are evaluated con-
sidering fGO values computed over the training sets
without including in the GO term counts of the corre-
sponding test set.
Support Vector Machine software
The LIBSVM package (http://www.csie.ntu.edu.tw/
~cjlin/libsvm/) has been used for the SVM implementa-
tion [42]. The selected SVM kernel is a Radial Basis
Function (RBF) kernel K(xi,xj)=exp(-g||xi-xj||
2) and g and
C parameters are optimized performing a grid like
search. After input rescaling the values of the best para-
meters are C=8 and g=0.03125
Statistical indexes for accuracy measure
The performances of our methods are evaluated using a
20-fold cross-validation procedure on the whole SAPs
dataset. The dataset has been divided keeping the ratio
of the disease-related to the neutral polymorphism
mutations similar to the original distribution of the
whole set. To avoid the presence of homolog proteins in
both training and testing sets, all the proteins in the
datasets are clustered according to their sequence simi-
larity with the blastclust program in the BLAST suite
[36] by adopting the default value of length coverage
equal to 0.9 and the percentage similarity threshold
equal to 30%. We kept all the mutations belonging to a
protein in the same training set to avoid overestimation
of the performance. In this paper the efficiency of our
predictors have been scored using the following statisti-
cal indexes.
The overall accuracy is:
Q2=P/T (3)
where P is the total number of correctly predicted class
of mutations and T is the total number of mutations. The
Matthew’s correlation coefficient C is defined as:
C(s)=[p(s)n(s)-u(s)o(s)] / W (4)
where W is the normalization factor:
W=[(p(s)+u(s))(p(s)+o(s))(n(s)+u(s))(n(s)+o(s))]1/2 (5)
for each class s (D and N, stand for disease-related
and neutral mutations respectively); p(s) and n(s) are the
total number of correct predictions and correctly
rejected assignments, respectively, and u(s) and o(s) are
the numbers of false negative and false positive for the
class s.
The coverage S (sensitivity) for each discriminated
class s is evaluated as:
S(s)=p(s)/[p(s)+u(s)] (6)
where p(s) and u(s) are the same as in Equation 5.
The probability of correct predictions P (or positive
predictive values) is computed as:
P(s)=p(s) / [p(s) + o(s)] (7)
where p(s) and o(s) are the same as in Equation 5
(ranging from 0 to 1).
For each prediction a reliability score (RI) is calculated
as follows:
RI=20*abs |O(D)-0.5| (8)
where O(D) ranges from 0 to 1 and it is the probabil-
ity associated to the class disease-related (D) returned
when LIBSVM is run with the probability estimation
option. Other standard scoring measures, such as the
area under the ROC curve (AUC) and the true positive
rate (TPR= Q(s)) at 10% of False Positive Rate (FPR= 1-
P(s)) are also computed [43].
Interaction score
The residues interactions are defined considering all the
residues within a radius shell of 6 Å around the C-a of
the mutated residue. According to this we calculate a
log odd score dividing the frequency of lost interactions
related to disease by the same type of interactions that
have no pathological effect.
Although the mutations could be responsible for pro-
tein structural changes, as first approximation, we con-
sider the position of the C-a of the new residue will not
change significantly after the mutation. Hence, we con-
sider gained interactions those between the mutant resi-
due and the residues previously interacting with the wild-
type. The score of the possible damaging effect of inter-
actions is computed as follow
LC=log2[f(c(i,j),D)/f(c(i,j),N)] (9)
where fk(c(i,j),D) and f(c(i,j),N) are the frequencies of
contacts between residues i and j respectively for dis-
ease-related (D) and neutral (N) variants. The LC
score has been calculated both for lost and gained
interactions and are available in the Additional file 2
and 3 respectively.
Capriotti and Altman BMC Bioinformatics 2011, 12(Suppl 4):S3
http://www.biomedcentral.com/1471-2105/12/S4/S3
Page 9 of 11
Additional material
Additional file 1: List of Single Amino Acid Polymorphisms in our
datasets.
Additional file 2: Log-odd scores for lost residues pair interactions.
Additional file 3: Log-odd scores for gained residues pair
interactions.
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